Showing results (121-130 of 309) with videos related to

Sort By:
Pageof 31
Frontiers in Cellular and Infection Microbiology|February 6, 2023
Characterization of serum biomarkers and antibody responses against Prevotella spp. in preclinical and new-onset phase of rheumatic diseasesLena Amend, Benoît Thomas P Gilbert, Penelope Pelczar, et al.
Frontiers in Immunology|June 25, 2026
Antibodies against Ro52 in idiopathic inflammatory myopathies are associated with objective sicca symptomsAnna Meinecke, Benjamin Seeliger, Jonas C Schupp, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 16, 2009
B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE)Lena Schiffer, Philipp Kümpers, Ana M Davalos-Misslitz, et al.
Retrovirology|March 13, 2016
TLR8 regulation of LILRA3 in monocytes is abrogated in human immunodeficiency virus infection and correlates to CD4 counts and virus loadsHui Zhi Low, Gerrit Ahrenstorf, Claudia Pommerenke, et al.
Zeitschrift Fur Rheumatologie|November 3, 2025
[Patient satisfaction in patients with rheumatoid arthritis : Effects of delegation to rheumatological specialist assistants]Birte Luise Hägermann, Juliana Rachel Hoeper, Sara Eileen Meyer, et al.
Arthritis and Rheumatism|December 2, 2009
Depletion of functionally active CD20+ T cells by rituximab treatmentEsther Wilk, Torsten Witte, Nicole Marquardt, et al.
European Neurology|December 21, 2016
Cerebrospinal Fluid Findings in Neurological Diseases Associated with Sjögren's SyndromeKaweh Pars, Refik Pul, Philipp Schwenkenbecher, et al.
Arthritis and Rheumatism|December 2, 2005
The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysisYoung Ho Lee, Torsten Witte, Tanja Momot, et al.
International Journal of Environmental Research and Public Health|June 16, 2018
Tuberculosis Specific Interferon-Gamma Production in a Current Refugee Cohort in Western EuropeAlexandra Jablonka, Christian Dopfer, Christine Happle, et al.
Contemporary Clinical Trials Communications|October 20, 2022
The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trialMáté Krausz, Annette Uhlmann, Ina Caroline Rump, et al.
Pageof 31